Search

everythinglearnresearchcommunity

for

Search:↓

Most hospitalized COVID-19 patients had long-term symptoms like fatigue and hair loss, with women and those sicker during hospitalization at higher risk.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

COVID-19 can cause skin changes, possibly from the virus, drugs, or lifestyle changes.

COVID-19 vaccination may cause kidney inflammation, treatable with steroids and Cellcept.

COVID-19 can cause skin issues like "COVID toes," rashes, hair loss, and hand eczema, and dermatologists are important for recognizing these signs.

AGA linked to worse COVID-19 outcomes in men.

COVID-19 can cause skin problems directly or from using protective gear and sanitizers, and knowing this can help treat patients better.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

Long COVID affects many survivors, showing the need for ongoing care.

COVID-19 vaccines are generally safe for people with lupus, though some may experience mild flare symptoms.

COVID-19 can cause various skin problems, including reactions to protective gear and medication, with different rates reported worldwide, and more research is needed to fully understand these skin issues.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Androgens and a high-fat diet may increase the risk of severe COVID-19 in women with PCOS by upregulating certain proteins in the heart and kidneys.

COVID-19 can cause skin symptoms that might help spot the virus early, and treatments for it can also affect the skin.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

Men with more CAG repeats in the androgen receptor gene and lower testosterone levels may experience more severe COVID-19.

Severe male balding may increase the risk of serious COVID-19, and treatments that reduce androgens or block a specific enzyme might help protect these individuals.

Hair loss link to severe COVID-19 unclear.

High incidence of hair loss found in COVID-19 patients, but no severity correlation established.

Higher dihydrotestosterone may be linked to more inflammation in COVID-19 patients with low testosterone.

COVID-19 affects multiple body systems and complicates treatment; accurate testing is crucial.

Skin symptoms linked to COVID-19 are hard to confirm, and more testing is needed to identify which are truly caused by the virus.

A COVID-19 patient had unusual nail discoloration and nail separation possibly due to the virus's effects on small blood vessels.

Most COVID-19 survivors developed post-acute symptoms, especially if they had been in the ICU, but the severity of initial infection didn't predict these symptoms.

Some COVID-19 pneumonia patients in Veracruz, Mexico, had skin issues, with reversible hair loss linked to disease severity.

Canakinumab's effect on COVID-19 outcomes is unclear.

Some drugs may help treat both COVID-19 and radiation injury.

MAIT cells may help fight COVID-19 but also contribute to severe inflammation.

Some COVID-19 pneumonia patients in Veracruz, Mexico had rare skin issues like temporary hair loss linked to disease severity.

Certain skin rashes can indicate COVID-19 severity, with chilblains-like rashes linked to milder cases and livedoid patterns to more severe cases.